Valneva says Chikungunya vaccine phase-III trial has met primary endpoint
In August, after Valneva gave a positive update on the phase-III trial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Chikungunya vaccine
IVI and Bharat Biotech launch Global Chikungunya Vaccine phase-II/III trial in Costa Rica
IVI is advancing clinical development of BBV87 through a phase-II/III randomised, controlled trial to evaluate the safety and…
Themis Bioscience appoints Dr Philippe Dro and Dr Christian Mandl
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine